15-deoxy-Δ¹²,¹⁴ -prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome prolifer

scientific article published on 9 April 2012

15-deoxy-Δ¹²,¹⁴ -prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome prolifer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JNR.23051
P698PubMed publication ID22487967

P50authorSuh Yoo-hunQ15994143
P2093author name stringYoung Hae Chong
Sang Eun Kim
Ji Hye Yang
Eun Ok Lee
Ji Hee Lee Kang
P2860cites workMCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosisQ24301992
Concomitant degradation of beta-catenin and GSK-3 beta potently contributes to glutamate-induced neurotoxicity in rat hippocampal slice culturesQ28570960
Fat and beyond: the diverse biology of PPARgammaQ29615416
Mechanisms underlying inflammation in neurodegenerationQ29617977
A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgammaQ31938741
Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A ReviewQ33753132
Pathogenesis of HIV in the central nervous systemQ33781978
15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signalingQ34208174
Biomarkers of neurological status in HIV infection: a 3-year studyQ35625987
Heme oxygenase-1: from bench to bedsideQ36131644
NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activationQ36162132
Organotypic hippocampal slice cultures: a model system to study basic cellular and molecular mechanisms of neuronal cell death, neuroprotection, and synaptic plasticityQ36346042
Mechanisms of neuronal injury and death in HIV-1 associated dementiaQ36536180
Current understanding of HIV-associated neurocognitive disorders pathogenesisQ36932005
Roles of MCP-1 in development of HIV-dementiaQ37175209
The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART eraQ37193610
15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.Q37280765
NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat.Q37304937
The anti-inflammatory effects of prostaglandins.Q37400560
Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetesQ37455841
Inflammation and NF-kappaB in Alzheimer's disease and diabetes.Q37455846
Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2.Q37539108
Functions of Tat: the versatile protein of human immunodeficiency virus type 1.Q37610674
Heme oxygenase-1: its therapeutic roles in inflammatory diseasesQ37682606
Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infectionQ37726311
Potential predictors of hippocampal atrophy in Alzheimer's diseaseQ37822719
Neurocognitive impairment and neuroCART.Q37872561
15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292).Q39839976
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cellsQ40018278
Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cellsQ40154397
Protection of RPE cells from oxidative injury by 15-deoxy-delta12,14-prostaglandin J2 by augmenting GSH and activating MAPK.Q40215464
The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.Q40474751
A macrophage hippocampal slice co-culture system: application to the study of HIV-induced brain damageQ40923652
Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons.Q41863627
Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neuronsQ43051856
Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependentQ43108484
CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiatesQ43123425
Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endotheliumQ43270952
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.Q44001857
15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytesQ44801463
Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonistsQ44900417
The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expressionQ45764762
15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS.Q46167786
Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline.Q46171858
PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathwaysQ46655077
Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptorQ46873640
Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in miceQ47990486
ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice culturesQ48530200
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease.Q51411852
Dementia with features of Alzheimer's disease and HIV-associated dementia in an elderly man with AIDS.Q53301531
Cyclic AMP inhibition of tumor necrosis factor alpha production induced by amyloidogenic C-terminal peptide of Alzheimer's amyloid precursor protein in macrophages: involvement of multiple intracellular pathways and cyclic AMP response element bindiQ53357204
P433issue9
P304page(s)1732-1742
P577publication date2012-04-09
P1433published inJournal of Neuroscience ResearchQ6295654
P1476title15-deoxy-Δ¹²,¹⁴ -prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome prolifer
P478volume90

Reverse relations

cites work (P2860)
Q5424978215-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
Q61849157CD200R1 and CD200 expression are regulated by PPAR-γ in activated glial cells
Q46973254Comparison of anti-inflammatory potential of four different dibenzocyclooctadiene lignans in microglia; action via activation of PKA and Nrf-2 signaling and inhibition of MAPK/STAT/NF-κB pathways
Q35559749Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice
Q34469655In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes
Q37746168M2 microglia promotes neurogenesis and oligodendrogenesis from neural stem/progenitor cells via the PPARγ signaling pathway
Q38977487Neuroinflammation in liver disease: sessional talks from ISHEN.
Q37547409Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication
Q38246264Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines?
Q97524620Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
Q38212101Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors
Q38366762Targeting HIV transcription: the quest for a functional cure

Search more.